Login / Signup

What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis.

Yvonne L Luigjes-HuizerNina Møller TauberGerald M HumphrisNadine A KasparianWendy Wing Tak LamSophie LebelSébastien SimardAllan 'Ben' SmithRobert ZachariaeYati AfiyantiKaty J L BellJosé A E CustersNiek J De WitPeter L FisherJacqueline GalicaSheila N GarlandCharles W HelsperMette Moustgaard JeppesenJianlin LiuRoxana MititeluEvelyn M MonninkhofLahiru RussellJosée SavardAnne E M SpeckensSanne Jasperine van HelmondtSina VatandoustNicholas ZdenkowskiMarije Liesbeth van der Lee
Published in: Psycho-oncology (2022)
FCR affects a considerable number of cancer survivors and patients. It is therefore important that healthcare providers discuss this issue with their patients and provide treatment when needed. Further research is needed to investigate how best to prevent and treat FCR and to identify other factors associated with FCR. The protocol was prospectively registered (PROSPERO CRD42020142185).
Keyphrases
  • end stage renal disease
  • healthcare
  • ejection fraction
  • newly diagnosed
  • systematic review
  • chronic kidney disease
  • prognostic factors
  • randomized controlled trial
  • risk factors
  • lymph node metastasis
  • meta analyses